Product
Anti-human CCL24
1 clinical trial
1 indication
Indication
Primary Sclerosing CholangitisClinical trial
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Evaluating the Safety and Efficacy of CM-101 in Subjects With Primary Sclerosing Cholangitis (The SPRING Study)Status: Active (not recruiting), Estimated PCD: 2024-09-01